These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 28823082)
1. MiR-3910 Promotes the Growth and Migration of Cancer Cells in the Progression of Hepatocellular Carcinoma. Cheng L; Wang H; Han S Dig Dis Sci; 2017 Oct; 62(10):2812-2820. PubMed ID: 28823082 [TBL] [Abstract][Full Text] [Related]
2. Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1. Qiu Y; Huang D; Sheng Y; Huang J; Li N; Zhang S; Hong Z; Yin X; Yan J Exp Cell Res; 2021 Aug; 405(1):112646. PubMed ID: 34029571 [TBL] [Abstract][Full Text] [Related]
3. TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway. Shu B; Zhou Y; Lei G; Peng Y; Ding C; Li Z; He C Cancer Sci; 2024 May; 115(5):1476-1491. PubMed ID: 38475938 [TBL] [Abstract][Full Text] [Related]
4. microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit. Shi X; Liu TT; Yu XN; Balakrishnan A; Zhu HR; Guo HY; Zhang GC; Bilegsaikhan E; Sun JL; Song GQ; Weng SQ; Dong L; Ott M; Zhu JM; Shen XZ Oncogene; 2020 Aug; 39(35):5768-5781. PubMed ID: 32719439 [TBL] [Abstract][Full Text] [Related]
5. A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma. Guo C; Gao C; Zhao D; Li J; Wang J; Sun X; Liu Q; Hao L; Greenaway FT; Tian Y; Liu S; Sun MZ J Exp Clin Cancer Res; 2020 Apr; 39(1):70. PubMed ID: 32326970 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068 [TBL] [Abstract][Full Text] [Related]
7. Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma. Wang JT; Wang ZH Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7233-7239. PubMed ID: 30468466 [TBL] [Abstract][Full Text] [Related]
8. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway. Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734 [TBL] [Abstract][Full Text] [Related]
9. Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway. Lou G; Dong X; Xia C; Ye B; Yan Q; Wu S; Yu Y; Liu F; Zheng M; Chen Z; Liu Y J Exp Clin Cancer Res; 2016 Jan; 35():14. PubMed ID: 26790956 [TBL] [Abstract][Full Text] [Related]
10. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway. Tan S; Li R; Ding K; Lobie PE; Zhu T FEBS Lett; 2011 Jul; 585(14):2229-34. PubMed ID: 21658389 [TBL] [Abstract][Full Text] [Related]
11. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4. Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906 [TBL] [Abstract][Full Text] [Related]
12. LINC00473 promotes hepatocellular carcinoma progression via acting as a ceRNA for microRNA-195 and increasing HMGA2 expression. Mo J; Li B; Zhou Y; Xu Y; Jiang H; Cheng X; Wu X; Zhang Y Biomed Pharmacother; 2019 Dec; 120():109403. PubMed ID: 31562977 [TBL] [Abstract][Full Text] [Related]
13. miR-107 promotes hepatocellular carcinoma cell proliferation by targeting Axin2. Zhang JJ; Wang CY; Hua L; Yao KH; Chen JT; Hu JH Int J Clin Exp Pathol; 2015; 8(5):5168-74. PubMed ID: 26191213 [TBL] [Abstract][Full Text] [Related]
14. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis. Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion via Targeting LASP1 in Hepatocarcinoma Cells. Li H; Xiang Z; Liu Y; Xu B; Tang J Oncol Res; 2017 Sep; 25(8):1269-1282. PubMed ID: 28117027 [TBL] [Abstract][Full Text] [Related]
16. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma. Wei GY; Hu M; Zhao L; Guo WS Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5158-5167. PubMed ID: 31298411 [TBL] [Abstract][Full Text] [Related]
17. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis. Sun DS; Guan CH; Wang WN; Hu ZT; Zhao YQ; Jiang XM Microvasc Res; 2021 Mar; 134():104120. PubMed ID: 33309645 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
19. miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma. Yang Q; Zhang L; Zhong Y; Lai L; Li X Biosci Rep; 2019 May; 39(5):. PubMed ID: 31048362 [TBL] [Abstract][Full Text] [Related]